Clinical Trials Logo

Clinical Trial Summary

The dramatic increase in the use of e-cigarettes among U.S. adolescents has been called a national epidemic, with more adolescents now using e-cigarettes than traditional cigarettes. The high amounts of nicotine in e-cigarettes harm adolescents and put them at greater risk of becoming traditional cigarette smokers. The investigators propose to develop Vaper-to-Vaper (V2V), a suite of mobile peer driven tools including peer texting and coaching based on lessons learned in the investigators' prior tobacco intervention work, to engage and help adolescents use strategies to manage cravings and successfully quit.


Clinical Trial Description

The FDA and the US Surgeon General call the increasing use of e-cigarettes among U.S. adolescents an epidemic, with e-cigarette use exceeding combustible cigarette use. The high amounts of nicotine in e-cigarettes harm adolescent brain development, impacting learning, memory, and attention. Adolescent e-cigarette users also are at higher risk than non-users of transitioning to traditional cigarettes. While prevention is important, evidence-based interventions to engage and help adolescent e-cigarette users quit are critically needed. Key challenges include adolescents perceiving e-cigarette use to be of low risk resulting in a low intention to quit, and the major influence of peers in e-cigarette use. Given there currently are no evidence-based cessation interventions to assist adolescent e-cigarette users in quitting, as suggested by the American Academy of Pediatrics and FDA, the investigators propose to develop Vaper-to-Vaper (V2V), a multi-modal mobile peer driven intervention, based on lessons learned in our prior tobacco intervention work. Peer-driven interventions have been found to successfully improve smoking outcomes in adolescents, and the investigators have had success in developing peer-driven interventions for low motivated adult smokers. The Investigators therefore will adapt these approaches for adolescent e-cigarette users. V2V's goal will be to engage, educate, motivate, and facilitate the adolescent in using strategies to manage cravings and successfully quit. The V2V components will include: Peer Messaging (tailored messages pushed via texting), Peer Coaching (asynchronous communications with trained coaches via texting), and Gamification (using game design to motivate participation). Adapting these tools to the unique needs of adolescent e-cigarette users will further extend these tools into novel directions. For Aim 1 the investigators will convene a peer advisory panel of 20 adolescent e-cigarette users to participate in a qualitative assessment and further development of V2V components. In Aim 2 the investigators will evaluate the feasibility of the research protocols and the feasibility and acceptability of the V2V intervention in a pilot feasibility study with eighty adolescent e-cigarette users from 4 high schools (schools randomized to either V2V intervention or control) recruited and followed for 6 months. The investigators hypothesize being able to recruit 80 adolescents (20/school, 40 per study condition) and that >85% will be retained in each study condition at 6-month follow-up (Aim 2A). For Aim 2b the investigators will monitor V2V engagement (e.g., number of V2V texting quizzes completed, peer coaching interactions, peer videos viewed) and assess acceptability of and satisfaction with the program. For Aim 2C the investigators hypothesize that the intervention will be associated with greater cotinine-validated 7-day point prevalence vaping abstinence rates, lower time to first quit attempt, and less amount of e-cigarette use compared to control at 6-month follow-up. This Stage I project, adapting an existing intervention and feasibility/pilot testing, will provide the necessary materials and information to proceed to a subsequent large-scale Stage III R01 trial to test the efficacy of the V2V intervention in supporting adolescent e-cigarette users in quitting. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05140915
Study type Interventional
Source University of Massachusetts, Worcester
Contact
Status Enrolling by invitation
Phase N/A
Start date December 19, 2022
Completion date April 30, 2025

See also
  Status Clinical Trial Phase
Completed NCT05037656 - Testing a School-Based E-cigarette, Tobacco, and Betel (Areca) Nut Use Prevention Curriculum for Guam Youths N/A
Recruiting NCT05454267 - Early Detection of Vaping-related Vascular Diseases
Enrolling by invitation NCT04678245 - Network Intervention to Prevent Vaping N/A
Recruiting NCT06297005 - The Impact of E-cigarettes During Pregnancy on Childhood Health Outcomes Study
Not yet recruiting NCT05999383 - Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration Phase 2
Completed NCT04522362 - Modeling Stress-precipitated Vaping Behavior N/A
Completed NCT04054765 - A Virtual Reality Videogame for E-cigarette Prevention in Teens N/A
Recruiting NCT06291597 - Vaping Adverse Lung and Heart Events Cohort
Active, not recruiting NCT04919590 - Text Message Quit Vaping Intervention for Adolescents N/A
Completed NCT04568395 - Acute Effects of TCIG vs ECIG in PLWH N/A
Completed NCT04707911 - Social Media Intervention to Stop Nicotine and Cannabis Vaping Among Adolescents N/A
Withdrawn NCT04340700 - Characterization of the Pharmacodynamic Response to Vaped THC Phase 3
Not yet recruiting NCT06335329 - Point-of-Care Ultrasound (POCUS) Findings and Impact on Vaping N/A
Completed NCT06433466 - Influencer Marketing: a Survey-based Experiment N/A
Active, not recruiting NCT05488743 - Smoking Prevention Program in Poland
Terminated NCT05240027 - To Vape or Not to Vape N/A
Recruiting NCT04661683 - Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol N/A
Completed NCT04450537 - PACE Vape Messaging Study N/A
Active, not recruiting NCT05367492 - Varenicline for Nicotine Vaping Cessation in Adolescents Phase 4
Completed NCT04879225 - Menthol and Mint Experimental Tobacco Marketplace (ETM) Study N/A